IDS and mucopolysaccharidosis type 2: Indeed, some investigators commented that the benefit obtained with idursulfase-IT in patients with MPS II may not be measured adequately with the assessment tools, and that the clinical impression that can be obtained by knowing the patient is more important than the test scores themselves.